Abstract
Baseline Biomarkers of T-Cell Function Correlate with Clinical Responses to Odronextamab (REGN1979), and Loss of CD20 Target Antigen Expression Identified As a Mechanism of Treatment Resistance
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have